The Canadian Institutes of Health Research (CIHR) has awarded four University of Ottawa Heart Institute (UOHI) research teams with important project funding exceeding a collective $3.2 million for future research that has potential to improve the health of all Canadians.
Below is a list of all awardees from the UOHI.
- Dr. Sharon Chih and Co-Principal Investigator Dr. George Wells
Project: Early Initiation of Antiplatelet ThERapy in HeArt TranspLantation - AERIAL Trial.
Amount: $566,100 over three years.
- *Dr. Han Kim
Project: The novel combinatorial role of Irx3 and Irx4 in ventricular non-compaction cardiomyopathy.
Amount: $742,050 over five years.
- *Dr. Pablo Nery and Co-Principal Investigators Drs. David Birnie and George Wells
Project: Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial.
Amount: $952,426 over five years.
- Dr. Atul Verma (UOHI affiliate investigator based at Southlake Regional Health Centre) and Co-Principal Investigator Dr. David Birnie
Project: The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial.
Amount: $956,250 over five years.
Projects marked with an asterisk (*) indicate proposals that ranked first in the review committee.
For more information or to coordinate an interview with one or more of the above-mentioned UOHI researchers, contact the liaison below.
Leigh B. Morris
University of Ottawa Heart Institute